Extrawell Pharmaceutical Holdings Limited

HK$0.05As of Sun 8 Nov 2026, 12:00 UTC
HKEX:0858Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR (15.17%)
Div yield —
ROE (114.34%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.06
PE TTM —
TSR TTM (45.65%)
Mkt cap HK$145.0M
ROIC (1.53%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0565
13.03%
(57.72%)
Hold 3|5|2|12|11
3Q26
4Q26
1Q27
2Q27
Earnings per share$
—
—
—
—
(6.41%)
(6.93%)
0.97%
0.20%
Revenue$M
8.686
8.967
8.849
9.183
4.23%
7.80%
4.05%
5.46%
Peers (US$18.50M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.804
(0.088)
(0.080)
EBIT/Intx
0.984
3.263
2.031
Own earn%
87.19
(230.21)
(229.58)
Sh yield%
28.33
33.53
35.00
Owners
Insiders/Inst%
10.38
64.32
Short interest%
1.81
SBC / revenue%
2.44
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
12–22
$1 testx
—
Incr. ROIC%
8